Dr. Uttam Kumar Sinha, MD

Dr. Sinha practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Sinha's NPI, 1518976901, was assigned on August 5, 2006. Dr. Sinha graduated from Other in 2012. Dr. Sinha holds California license A50115.

Dr. Sinha's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Sinha's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Sinha to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sinha practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Sinha's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Sinha is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Sinha's licenses on file in 2 states: California and New York.

Dmand AI lists chronic nasal allergies, ear eustachian tube disorders, endoscopic sinus surgery, larynx and vocal cord disease, swimmer's ear and thyroid surgery among the conditions Dr. Sinha treats.

CMS data shows 496 Medicare services from Dr. Sinha across 13 procedure codes in 2024, for 213 Medicare patients. Medicare paid $122,993 for them.

CMS counts 213 Medicare patients who saw Dr. Sinha in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sinha's median patient age at 70, with 41% women.

In 2024, Dr. Sinha wrote 37 Medicare Part D claims for 15 patients. 46% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $159 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

Dr. Sinha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sinha as offering telehealth. CMS counts 33 procedures of melanoma (skin cancer) excision by Dr. Sinha, more than 81% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Sinha, published from 2013 to 2019. 2015 was the busiest year, with 3. Dr. Sinha's most frequent co-authors are Mark S. Swanson, MD, Michael James Bauschard, MD, MS and Brian P. Cervenka, MD.

Dmand AI links Dr. Sinha to 1 clinical trial. Conditions studied include Colonic Neoplasms and Pancreatic Neoplasms.

CMS Open Payments shows 54 general payments to Dr. Sinha from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 57% of the total. Siemens Medical Solutions USA, Inc. paid the most, $9,553.

Dmand AI lists 10 awards for Dr. Sinha, most recently Top Doctors:LA Area in 2013.

Dr. Sinha graduated from Other in 2012. Dr. Sinha is a member of AOA, NHS and ACS.

Dr. Sinha is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.